Ribavirin has been studied for over 20 years as a potential therapy against a number of RNA and DNA viruses. It is well known that Ribavirin in combination with Interferon is a key antiviral component in the treatment of Hepatitis C virus infection. In this book, the authors discuss the biochemistry, clinical applications and potential side effects of Ribavirin. Topics include optimising Ribavirin use for the treatment of Hepatitis C; Ribavirin and its great potential in infectious diseases; the antiviral actions of Ribavirin; a novel prediction method for the responsiveness of Hepatitis C patients to drug treatment; and Ribavirins intolerable cough during HCV combination therapy which can be overcome by replacement with Nitazoxanide.
Preface; Optimizing Ribavirin Use for the Treatment of Hepatitis C; Ribavirin & its Great Potentials in Infectious Diseases; Antiviral Actions of Ribavirin; A Novel Prediction Method for the Responsiveness of Hepatitis C Patients to Drug Treatment; Ribavirin Intolerable Cough During HCV Combination Therapy Can Be Overcome by Nitazoxanide Replacement; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.